Iktos
Artificial intelligence for new drug discovery
Iktos has raised €16M across 1 funding round from 3 investors, most recently a Series A round in Mar 2023. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Franceiktos.ai ↗
Total raised
€16M
€15,500,000
Funding rounds
1
Investors
3
distinct backers
Active since
2023-03
latest 2023-03
Funding by year
EUR raised per yearIktos — funding by year — interactive chart.
Data table
| Iktos — funding by year | |
|---|---|
| 2023 | €16M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-09 | Series A | €16M | Debiopharm Innovation Fund,M Ventures,Omnes Capital | View deal → |
Related news
- France-based Iktos raises €15.5M to expand its AI-based drug discovery technologysiliconcanals.com · 2023-03
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData